Friday, 6 November 2026European Markets

ITERA, KITRON, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - itera (itera.ol) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
itera (itera.ol) kr11.50 3.46% 63.44%
kitron (kit.ol) kr34.88 2.12% 22.67%
lectra (lss.pa) €32.35 1.36% 8.07%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. itera (itera.ol)

3.46% forward dividend yield and 63.44% return on equity

itera asa, together with its subsidiaries, develops and operates digital solutions for businesses and organizations in norway, sweden, ukraine, denmark, czech republic, iceland, poland, and slovakia. it offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. the company provides a range of services in the strategy and consulting, customer experience, and technology and cloud transformation areas. it serves banking and insurance, energy and utilities, industry and manufacturing, health and public services, technology and communication, and products and retail industries. the company was founded in 1989 and is headquartered in oslo, norway.

earnings per share

as for profitability, itera has a trailing twelve months eps of kr0.59.

pe ratio

itera has a trailing twelve months price to earnings ratio of 19.49. meaning, the purchaser of the share is investing kr19.49 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.44%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on may 23, 2024, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 3.46%.

sales growth

itera's sales growth for the current quarter is 3.4%.

more news about itera.

2. kitron (kit.ol)

2.12% forward dividend yield and 22.67% return on equity

kitron asa operates as an electronics manufacturing services company in norway, sweden, denmark, lithuania, germany, poland, the czech republic, india, china, malaysia, and the united states. it manufactures and sells electronics that are embedded in the customer's own products; and box-built electronic products. the company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high-level assembly lines, and environmental durability testing. its services comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance, as well as logistics and distribution, and product deployment services. the company markets its services to connectivity, electrification, industry, medical devices, and defence/aerospace sectors. kitron asa was incorporated in 1996 and is headquartered in billingstad, norway.

earnings per share

as for profitability, kitron has a trailing twelve months eps of kr2.22.

pe ratio

kitron has a trailing twelve months price to earnings ratio of 15.71. meaning, the purchaser of the share is investing kr15.71 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.67%.

sales growth

kitron's sales growth is negative 6.8% for the ongoing quarter and 1046.9% for the next.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on apr 26, 2024, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.12%.

revenue growth

year-on-year quarterly revenue growth declined by 18.8%, now sitting on 719.8m for the twelve trailing months.

volume

today's last reported volume for kitron is 47549 which is 88.77% below its average volume of 423757.

more news about kitron.

3. lectra (lss.pa)

1.36% forward dividend yield and 8.07% return on equity

lectra sa provides industrial intelligence solutions for fashion, automotive, and furniture markets in northern europe, southern europe, the americas, and the asia pacific. the company designs, manufactures and markets end-to-end integrated technology solutions, which combines software, automated cutting equipment, and data, as well as associated services, including technical maintenance, support, training, and consulting. it also sells consumables and parts for its automated cutting equipment. lectra sa was incorporated in 1973 and is headquartered in paris, france.

earnings per share

as for profitability, lectra has a trailing twelve months eps of €0.91.

pe ratio

lectra has a trailing twelve months price to earnings ratio of 35.55. meaning, the purchaser of the share is investing €35.55 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.07%.

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 30, 2024, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 1.36%.

revenue growth

year-on-year quarterly revenue growth grew by 14.5%, now sitting on 500.31m for the twelve trailing months.

more news about lectra.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com